FDA advisory committee
This article was originally published in The Tan Sheet
Executive Summary
The Risk Communication Advisory Committee will meet May 15-16, 2008, in Rockville, Md., to discuss direct-to-consumer advertising, including how it relates to subsets of the population and the appropriateness of statements in the ads that encourage consumers to report negative side effects of prescription drugs to MedWatch, according to an FDA notice in the April 28 Federal Register. Consumers or groups interested in presenting oral comments should submit their position and arguments to the agency by May 8. Comments submitted through June 16 will be considered for a report on the issue, the agency says...